Melvin Seek, MD
Nephrology · Ocala, FLNPI 1043218043
Payments from drug & device makers
Across 76 payments — averaging $517.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$36K
- Abiomed$2K
- Nxstage Medical, Inc.$439
- Outset Medical Inc$297
- Coala Life Inc$176
- Baxter Healthcare$173
- plus $744 from 15 others
Across 12 payments — averaging $6308.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Quanta Dialysis Technologies Inc$76K
What the payments were for
- Food & beverage$3,37799%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 20 | $35,916 |
| Abiomed | 15 | $1,560 |
| Nxstage Medical, Inc. | 4 | $439 |
| Outset Medical Inc | 7 | $297 |
| Coala Life Inc | 1 | $176 |
| Baxter Healthcare | 4 | $173 |
| Amarin Pharma, Inc. | 3 | $134 |
| Vifor Pharma, Inc. | 1 | $125 |
| Boston Scientific | 2 | $85 |
| Akebia Therapeutics Inc | 4 | $82 |
| Medtronic | 2 | $50 |
| Penumbra, Inc. | 3 | $46 |
| AstraZeneca | 2 | $33 |
| AbbVie | 1 | $31 |
| Travere Therapeutics, Inc. | 1 | $27 |
| Mallinckrodt Enterprises LLC | 1 | $26 |
| Abbott | 1 | $25 |
| Exact Sciences | 1 | $25 |
| Amgen | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,130
- PUREFLOW SL$261
- NXSTAGE SYSTEM ONE$261
- Coala Heart Monitor$176
- Veltassa$125
- System One$118
- Vascepa$106
How this compares
$39,304 in reported general payments places this provider in the 85th percentile of 756 nephrology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 21 | $58,351 |
| OzempicSemaglutide | 12 | $12,133 |
| Sevelamer Carbonate | 35 | $5,364 |
| Clonidine | 23 | $4,537 |
| Calcium Acetate | 17 | $1,259 |
| Bumetanide | 12 | $1,153 |
| Carvedilol | 43 | $920 |
| Minoxidil | 17 | $886 |
| Pregabalin | 19 | $716 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $658 |
| Amlodipine Besylate | 56 | $625 |
| Rosuvastatin Calcium | 14 | $535 |
| Losartan Potassium | 45 | $494 |
| Lisinopril | 45 | $385 |
| Potassium Chloride | 12 | $375 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Ocala
- Thomas MarburyOrlando$41.1M
- Julio VijilHollywood$16.1M
- Steven ZeigHollywood$14.3M
- Oscar GalvezMiami$14.2M
- Jesus NavarroTampa$13.3M
- Arvind MadanOrlando$9.7M
- David HalpertAtlantis$4.2M
- Wayne KotzkerFort Lauderdale$3.4M
- Edouard MartinLauderdale Lakes$2.7M
- Jorge PosadaCoral Gables$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.